Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Lymphoma chronic lymphocytic

D26. Dunphy, C. H., Wheaton, S. E., and Perkins, S. L., CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic tranformations of mantle cell lymphoma. Mod. Pathol. 10, 818-822 (1997). [Pg.335]

K8. Kilo, M. N., and Dorfman, D. M., The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am. J. Clin. Pathol. 105, 451—457 (1996). [Pg.340]

In a placebo-controlled study of severely anemic patients with low-grade non-Hodgkin s lymphoma, chronic lymphocytic leukemia, or multiple myeloma, a fatal case of pulmonary embolism was thought to have been related to treatment with epoetin beta (95). Thrombotic events, such as vascular access thrombosis, venous thrombosis, and pulmonary embolism, have occurred after treatment with epoetin or darbepoetin alfa (96). It is therefore recommended that a rapid rise in the hemoglobin concentration be avoided and that care should be taken that the hemoglobin concentration does not exceed 12.1 g/dl (7.5 mmol/1) (97). [Pg.1247]

Lymphoma, chronic lymphocytic leukemia (15%), and Waldenstrom s macrpglobulinemia... [Pg.570]

Defective Synthesis (IgM Falls First, Then IgA, Finally IgG) Lymphoid malignancy, multiple myeloma, lymphoma, chronic lymphocytic leukemia Toxic reaction (e.g., renal failure, diabetes mellitus)... [Pg.572]

Multiple myeloma, B-cell lymphoma, chronic lymphocytic leukemia, Waldenstrom s macroglobuHnemia Insulinoma... [Pg.774]

CD25 functions as a low-affinity interleukin-2 receptor and may be found on a number of cell types including activated T cells. This antigen is characteristically expressed on hairy cell leukemia, mast cell lesions, and certain T-cell malignancies but may be seen at low levels in certain B-cell lymphomas, particularly small cell lymphocytic lymphoma/chronic lymphocytic leukemia. Targeted therapy is available for this antigen (Ontak). [Pg.158]

INTERPHASE FISH Several recurrent genetic abnormalities identified in small cell lymphocytic lymphoma/chronic lymphocytic leukemia have had a direct relationship to disease progression. These abnormalities are ... [Pg.170]

Cladribine, a purine nucleoside analog, with antineoplas-tic properties (0.09 mg/kg daily by continuous IV infusion for 7 days), is indicated in the treatment of active hairy cell leukemia. In addition, it has been used in advanced cutaneous T-cell lymphomas, chronic lymphocytic leukemia, non-Hodgkin s lymphomas, acute myeloid leukemias, autoimmune hemolytic anemia, mycosis fungoides, or Sezary syndrome (see also Figure 15). [Pg.160]

This translocation has been also sporadically described in few other malignancies such as some high-grade B-cell lymphoma (some of which maybe transformed from mantle cell lymphoma), chronic lymphocytic leukemia, hairy cell leukemia and multiple myeloma. [Pg.164]

Ibrutinib (Imbruvica) The First-in-Class Btk Inhibitor for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom s... [Pg.157]

Precursor B-cell neoplasm Precursor B-lymphoblastic leukemia/lymphoma Mature (peripheral) B-cell neoplasms B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma... [Pg.1374]

Cancers Multiple myeloma Non-Hodgkin s lymphoma Hodgkin s disease Acute myeloid leukemia Neuroblastoma Germ cell tumors Acute myeloid leukemia Acute lymphoblastic leukemia Chronic myeloid leukemia Myelodysplastic syndrome Myeloproliferative disorders Non-Hodgkin s lymphoma Hodgkin s disease Chronic lymphocytic leukemia Multiple myeloma... [Pg.1448]

Jones D, Benjamin RJ, Shahsafaei A, Dorfman DM. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood 2000 95 627-632. [Pg.346]

Hainsworth, J.D., Litchy, S., Barton, J.H., Houston, G.A., Hermann, R.C., Bradof, J.E., and Greco, RA., Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma a phase II trial of the Minnie Pearl Gancer Research Network, /. Clin. Oncol., 21,1746-2751, 2003. [Pg.584]

Plosker GL. Rituximab. A review of its use in non-Hodgkin s lymphoma and chronic lymphocytic leukaemia. Drugs 2003 63 803 3. [Pg.83]

The association between malaria and Burkitt s lymphoma, and between splenomegaly and chronic lymphocytic leukemia are perhaps the results of the long-term effects of an overworked thymolymphatic system. [Pg.155]

Malignancies of various types— multiple myelomatosis, Waldenstrom macroglobulinemia, chronic lymphocytic leukemia, reticulum cell sarcoma, Hodgkin s disease, Burkitt s lymphoma and other malignancies of the reticuloendothelial system... [Pg.226]

Vandewoestyne ML, Pede VC, Lambein KY et al (2011) Laser microdissection for the assessment of the clonal relationship between chronic lymphocytic leukemia/smaU lymphocytic lymphoma and proliferating B cells within lymph node pseudofolKcles. Leukemia 25 883-888... [Pg.225]

Hayden RE, Pratt G, Roberts C et al (2011) Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches. Leuk Lymphoma 53(4) 537-549... [Pg.225]

Willimott S, Baou M, Huf S et al (2007) Separate ceU culture conditions to promote proliferation or quiescent cell survival in chronic lymphocytic leukemia. Leuk Lymphoma 48 1647-1650... [Pg.225]

MM = multiple myeloma ATL = adult T-cell leukemia ALL = acute lymphoblastic leukemia CLL = chronic lymphocytic leukemia FCC = follicular center cell lymphoma DLC = diffuse large cell lymphoma TRB = T-cell rich B-cell lymphoma ALCL = anaplastic large cell lymphoma MALT = mucosa-associated lymphoid tissue-type lymphoma LC = lung cancer CMM = cutaneous malignant melanoma TCC = transitional cell carcinoma CSCC = cutaneous squamous cell carcinoma. [Pg.125]

Corticosteroids suppress proliferation of lymphocytic cells, thus they are useful at combating acute lymphoblastic or undifferentiated leukemia of childhood, chronic lymphocytic leukemia, Hodgkin s lymphoma, other lymphomas. Therapy is often initiated with a steroid in combination with other agents. There is no evidence of cross resistance to unrelated agents. Mostly prednison is used however at appropriate dosages similar effects can be obtained with other glucocorticosteroids. [Pg.458]

Alemtuzumab is a recombinant DNA-derived humanized monoclonal antibody used in the treatment of chronic lymphocytic leukemia and T-cell lymphoma. It targets CD52, a protein present on the surface of mature lymphocytes. Alemtuzumab has been associated with infusion-related events including hypotension, rigors, fever, shortness of breath, bron-chospasm, chills, and/or rash. Also reported were syncope, pulmonary infiltrates, cardiac arrhythmias, myocardial infarction and cardiac arrest. [Pg.461]

See other pages where Lymphoma chronic lymphocytic is mentioned: [Pg.202]    [Pg.1]    [Pg.570]    [Pg.572]    [Pg.1459]    [Pg.157]    [Pg.170]    [Pg.170]    [Pg.444]    [Pg.202]    [Pg.1]    [Pg.570]    [Pg.572]    [Pg.1459]    [Pg.157]    [Pg.170]    [Pg.170]    [Pg.444]    [Pg.489]    [Pg.54]    [Pg.150]    [Pg.584]    [Pg.78]    [Pg.1286]    [Pg.1286]    [Pg.468]    [Pg.579]    [Pg.409]    [Pg.18]    [Pg.92]    [Pg.126]    [Pg.452]   
See also in sourсe #XX -- [ Pg.15 , Pg.40 , Pg.160 , Pg.164 , Pg.185 , Pg.189 ]



SEARCH



Lymphoma

Lymphoma lymphocytic

Lymphomas lymphocytic lymphoma

Lymphomas lymphoma

© 2024 chempedia.info